CINCINNATI, Feb. 26, 2020 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ: VIVO), following the extremely successful launch of the Lyo-Ready qPCR mixes, is proud to introduce today its ...
Narrow-moat-rated Meridian Energy had a solid first half fiscal 2024, with EBITDA up 4% to NZD 443 million. The result was better than it appears, given dry weather reduced hydroelectric output and ...
We cut our fiscal 2025 EBITDA forecast by 12% to NZD 895 million for narrow-moat-rated Meridian Energy. Expensive hedging to cover a shortfall in hydroelectric generation has led to a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback